5-trans-PGF2α, also known as 5-trans-prostaglandin F2α, is a naturally occurring prostaglandin that plays a significant role in various physiological processes, including regulation of blood flow, inflammation, and reproductive functions. It is characterized by its structure, which includes a cyclopentane ring and multiple functional groups, including hydroxyl and carboxylic acid groups, contributing to its biological activity. This compound is known for its potent vasodilatory effects and involvement in uterine contractions, making it relevant in reproductive health and pharmacology. 5-trans-PGF2α is typically synthesized from arachidonic acid through enzymatic pathways and can be found in various tissues. Its stability and reactivity are influenced by environmental conditions, such as pH and temperature. In research and clinical settings, it is often studied for its therapeutic potential in conditions like glaucoma and for its role in labor induction. As with many prostaglandins, its effects are mediated through specific receptors, leading to a range of biological responses.

5-trans-PGF2α

36150-01-3:   5-trans-PGF2a, Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5E,9α,11α,13E,15S)-, 5,6-trans-PGF2a,   5-trans-Prostaglandin F2a,   5,6-trans-Prostaglandin F2a, (5E,9α,11α,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid, 5,6-trans-Prostaglandin F2α, 5-trans-Prostaglandin F2α, 5,6-trans-PGF2α

CAS 36150-01-3: 5-trans-PGF2α

Dinoprost EP Impurity A

Ref: ST-EA-CP-D116001